United States Biologics Market Report 2016

Table of Contents

United States Biologics Market Report 2016
1 Biologics Overview
1.1 Product Overview and Scope of Biologics
1.2 Classification of Biologics
1.2.1 Monoclonal Antibodies (MAb) Technology
1.2.2 Recombinant DNA Technology (rDNA technology)
1.2.3 Nuclear magnetic resonance (NMR) technology
1.2.4 Chromatography
1.2.5 Electrophoresis
1.2.6 Mass Spectrometry
1.2.7 Western Blotting
1.2.8 Bioassay
1.3 Application of Biologics
1.3.1 Tumor
1.3.2 Diabetes
1.3.3 Cardiovascular
1.3.4 Hemophilia
1.3.5 Other
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Biologics (2011-2021)
1.4.1 United States Biologics Sales and Growth Rate (2011-2021)
1.4.2 United States Biologics Revenue and Growth Rate (2011-2021)

2 United States Biologics Competition by Manufacturers
2.1 United States Biologics Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Biologics Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Biologics Average Price by Manufactures (2015 and 2016)
2.4 Biologics Market Competitive Situation and Trends
2.4.1 Biologics Market Concentration Rate
2.4.2 Biologics Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Biologics Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Biologics Sales and Market Share by Type (2011-2016)
3.2 United States Biologics Revenue and Market Share by Type (2011-2016)
3.3 United States Biologics Price by Type (2011-2016)
3.4 United States Biologics Sales Growth Rate by Type (2011-2016)

4 United States Biologics Sales (Volume) by Application (2011-2016)
4.1 United States Biologics Sales and Market Share by Application (2011-2016)
4.2 United States Biologics Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 United States Biologics Manufacturers Profiles/Analysis
5.1 Pfizer
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Biologics Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Pfizer Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Roche
5.2.2 Biologics Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Roche Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Amgen
5.3.2 Biologics Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Amgen Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 AbbVie
5.4.2 Biologics Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 AbbVie Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Sanofi
5.5.2 Biologics Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Sanofi Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Johnson & Johnson
5.6.2 Biologics Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Johnson & Johnson Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Novo Nordisk
5.7.2 Biologics Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Novo Nordisk Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Novartis
5.8.2 Biologics Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Novartis Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Merck
5.9.2 Biologics Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Merck Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Lilly
5.10.2 Biologics Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Lilly Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 3sbio
5.12 Changchun high tech
5.13 CP Guojian Pharmacy
5.14 Biotech Pharma
5.15 Gelgen Biopharma
5.16 Sandoz
5.17 Teva
5.18 Hospira
5.19 Mylan
5.20 3sbio
5.21 Changchun high tech
5.22 CP Guojian Pharmacy
5.23 Biotech Pharma
5.24 Gelgen Biopharma

6 Biologics Manufacturing Cost Analysis
6.1 Biologics Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Biologics

7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Biologics Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Biologics Major Manufacturers in 2015
7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List

9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 United States Biologics Market Forecast (2016-2021)
10.1 United States Biologics Sales, Revenue Forecast (2016-2021)
10.2 United States Biologics Sales Forecast by Type (2016-2021)
10.3 United States Biologics Sales Forecast by Application (2016-2021)
10.4 Biologics Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer


List of Tables and Figures

Figure Picture of Biologics
Table Classification of Biologics
Figure United States Sales Market Share of Biologics by Type in 2015
Figure Monoclonal Antibodies (MAb) Technology Picture
Figure Recombinant DNA Technology (rDNA technology) Picture
Figure Nuclear magnetic resonance (NMR) technology Picture
Figure Chromatography Picture
Figure Electrophoresis Picture
Figure Mass Spectrometry Picture
Figure Western Blotting Picture
Figure Bioassay Picture
Table Application of Biologics
Figure United States Sales Market Share of Biologics by Application in 2015
Figure Tumor Examples
Figure Diabetes Examples
Figure Cardiovascular Examples
Figure Hemophilia Examples
Figure Other Examples
Figure United States Biologics Sales and Growth Rate (2011-2021)
Figure United States Biologics Revenue and Growth Rate (2011-2021)
Table United States Biologics Sales of Key Manufacturers (2015 and 2016)
Table United States Biologics Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Biologics Sales Share by Manufacturers
Figure 2016 Biologics Sales Share by Manufacturers
Table United States Biologics Revenue by Manufacturers (2015 and 2016)
Table United States Biologics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Biologics Revenue Share by Manufacturers
Table 2016 United States Biologics Revenue Share by Manufacturers
Table United States Market Biologics Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Biologics Average Price of Key Manufacturers in 2015
Figure Biologics Market Share of Top 3 Manufacturers
Figure Biologics Market Share of Top 5 Manufacturers
Table United States Biologics Sales by Type (2011-2016)
Table United States Biologics Sales Share by Type (2011-2016)
Figure United States Biologics Sales Market Share by Type in 2015
Table United States Biologics Revenue and Market Share by Type (2011-2016)
Table United States Biologics Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Biologics by Type (2011-2016)
Table United States Biologics Price by Type (2011-2016)
Figure United States Biologics Sales Growth Rate by Type (2011-2016)
Table United States Biologics Sales by Application (2011-2016)
Table United States Biologics Sales Market Share by Application (2011-2016)
Figure United States Biologics Sales Market Share by Application in 2015
Table United States Biologics Sales Growth Rate by Application (2011-2016)
Figure United States Biologics Sales Growth Rate by Application (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Biologics Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Biologics Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Biologics Sales Market Share (2011-2016)
Table AbbVie Basic Information List
Table AbbVie Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table AbbVie Biologics Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Biologics Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Biologics Sales Market Share (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novo Nordisk Biologics Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Biologics Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Biologics Sales Market Share (2011-2016)
Table Lilly Basic Information List
Table Lilly Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lilly Biologics Sales Market Share (2011-2016)
Table 3sbio Basic Information List
Table 3sbio Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table 3sbio Biologics Sales Market Share (2011-2016)
Table Changchun high tech Basic Information List
Table Changchun high tech Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Changchun high tech Biologics Sales Market Share (2011-2016)
Table CP Guojian Pharmacy Basic Information List
Table CP Guojian Pharmacy Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table CP Guojian Pharmacy Biologics Sales Market Share (2011-2016)
Table Biotech Pharma Basic Information List
Table Biotech Pharma Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biotech Pharma Biologics Sales Market Share (2011-2016)
Table Gelgen Biopharma Basic Information List
Table Gelgen Biopharma Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gelgen Biopharma Biologics Sales Market Share (2011-2016)
Table Sandoz Basic Information List
Table Sandoz Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sandoz Biologics Sales Market Share (2011-2016)
Table Teva Basic Information List
Table Teva Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Biologics Sales Market Share (2011-2016)
Table Hospira Basic Information List
Table Hospira Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hospira Biologics Sales Market Share (2011-2016)
Table Mylan Basic Information List
Table Mylan Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mylan Biologics Sales Market Share (2011-2016)
Table 3sbio Basic Information List
Table 3sbio Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table 3sbio Biologics Sales Market Share (2011-2016)
Table Changchun high tech Basic Information List
Table Changchun high tech Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Changchun high tech Biologics Sales Market Share (2011-2016)
Table CP Guojian Pharmacy Basic Information List
Table CP Guojian Pharmacy Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table CP Guojian Pharmacy Biologics Sales Market Share (2011-2016)
Table Biotech Pharma Basic Information List
Table Biotech Pharma Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biotech Pharma Biologics Sales Market Share (2011-2016)
Table Gelgen Biopharma Basic Information List
Table Gelgen Biopharma Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gelgen Biopharma Biologics Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biologics
Figure Manufacturing Process Analysis of Biologics
Figure Biologics Industrial Chain Analysis
Table Raw Materials Sources of Biologics Major Manufacturers in 2015
Table Major Buyers of Biologics
Table Distributors/Traders List
Figure United States Biologics Production and Growth Rate Forecast (2016-2021)
Figure United States Biologics Revenue and Growth Rate Forecast (2016-2021)
Table United States Biologics Production Forecast by Type (2016-2021)
Table United States Biologics Consumption Forecast by Application (2016-2021)

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.